Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Wenjun Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5335-7386; OpenAlex author ID A5100446244. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Targeting GJB4 to inhibit tumor growth and induce ferroptosis in pancreatic cancer. First author DOI 10.3389/fonc.2025.1585236↗
  2. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1132424↗
  3. Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells. Co-author DOI 10.1007/s13277-013-1301-2↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ping Bie · 1 shared paper, 2025 · strength 0.28
  2. Xiangru Zheng · 1 shared paper, 2025 · strength 0.28
  3. Junliang Chen · 1 shared paper, 2023 · strength 0.24
  4. Xiaodong Tan · 1 shared paper, 2023 · strength 0.24
  5. Zhengfa Mao · 1 shared paper, 2014 · strength 0.06
  6. Lei Cui · 1 shared paper, 2014 · strength 0.06
  7. Xin Fan · 1 shared paper, 2014 · strength 0.06
  8. Xu‐Qing Wang · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.